TCL Archive Panel Recommends Against Pooling Results Of NLST, European Studies, And I-ELCAP. NIH Director Zerhouni To Step Down At End Of October; Six-Year Tenure Brought Many Changes To NIH. September 26, 2008
TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008
TCL Archive NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction April 28, 2006
